Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 7 | 2024 | 958 | 2.590 |
Why?
|
| Astrocytes | 4 | 2024 | 250 | 2.190 |
Why?
|
| Intracranial Pressure | 3 | 2018 | 176 | 1.620 |
Why?
|
| Vascular Remodeling | 2 | 2021 | 41 | 1.440 |
Why?
|
| Neural Stem Cells | 2 | 2023 | 126 | 1.410 |
Why?
|
| Cerebral Hemorrhage | 3 | 2017 | 142 | 1.120 |
Why?
|
| Hippocampus | 2 | 2024 | 812 | 1.080 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2024 | 64 | 0.940 |
Why?
|
| Lateral Ventricles | 2 | 2023 | 14 | 0.890 |
Why?
|
| Mental Recall | 1 | 2024 | 140 | 0.890 |
Why?
|
| Neurons | 5 | 2024 | 1927 | 0.810 |
Why?
|
| Learning | 1 | 2024 | 361 | 0.740 |
Why?
|
| Recovery of Function | 3 | 2024 | 437 | 0.720 |
Why?
|
| Movement | 1 | 2020 | 167 | 0.640 |
Why?
|
| Hematoma | 2 | 2016 | 92 | 0.630 |
Why?
|
| Acetazolamide | 1 | 2018 | 30 | 0.620 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2018 | 24 | 0.620 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 73 | 0.600 |
Why?
|
| Wireless Technology | 1 | 2018 | 10 | 0.590 |
Why?
|
| Parenchymal Tissue | 1 | 2017 | 2 | 0.570 |
Why?
|
| Catheters | 1 | 2018 | 89 | 0.570 |
Why?
|
| Inflammation | 1 | 2024 | 1402 | 0.550 |
Why?
|
| Catheterization | 1 | 2018 | 234 | 0.530 |
Why?
|
| Animals | 17 | 2024 | 33720 | 0.480 |
Why?
|
| Iron | 1 | 2016 | 261 | 0.460 |
Why?
|
| Brain | 6 | 2024 | 2946 | 0.400 |
Why?
|
| Neuronal Plasticity | 2 | 2024 | 274 | 0.390 |
Why?
|
| Oxidative Stress | 1 | 2016 | 796 | 0.380 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2018 | 1211 | 0.370 |
Why?
|
| Carcinogenesis | 2 | 2024 | 327 | 0.370 |
Why?
|
| Rats | 4 | 2018 | 3631 | 0.360 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 4268 | 0.350 |
Why?
|
| Neurogenesis | 2 | 2023 | 196 | 0.340 |
Why?
|
| Mice | 9 | 2024 | 17486 | 0.320 |
Why?
|
| Brain Neoplasms | 3 | 2024 | 1217 | 0.260 |
Why?
|
| Cerebrovascular Circulation | 4 | 2024 | 424 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 4345 | 0.250 |
Why?
|
| Microvessels | 2 | 2024 | 56 | 0.240 |
Why?
|
| Ependymoma | 1 | 2024 | 133 | 0.210 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 534 | 0.210 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 665 | 0.210 |
Why?
|
| Kidney Calculi | 1 | 2002 | 40 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 414 | 0.190 |
Why?
|
| Male | 10 | 2024 | 60038 | 0.180 |
Why?
|
| Histones | 1 | 2024 | 526 | 0.180 |
Why?
|
| Cerebellar Neoplasms | 1 | 2024 | 282 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 1 | 2021 | 330 | 0.170 |
Why?
|
| Rodentia | 1 | 2019 | 46 | 0.170 |
Why?
|
| Forelimb | 1 | 2019 | 14 | 0.160 |
Why?
|
| Stroke Rehabilitation | 1 | 2019 | 60 | 0.160 |
Why?
|
| Brain Infarction | 1 | 2019 | 30 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 576 | 0.160 |
Why?
|
| Nervous System | 1 | 2019 | 128 | 0.160 |
Why?
|
| Glioma | 1 | 2023 | 491 | 0.160 |
Why?
|
| Transcriptome | 2 | 2024 | 908 | 0.150 |
Why?
|
| Light | 1 | 2019 | 175 | 0.150 |
Why?
|
| Arteries | 1 | 2019 | 222 | 0.150 |
Why?
|
| Neovascularization, Physiologic | 1 | 2019 | 211 | 0.150 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 434 | 0.140 |
Why?
|
| Telemetry | 1 | 2017 | 27 | 0.140 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2016 | 4 | 0.140 |
Why?
|
| Brain Ischemia | 1 | 2019 | 251 | 0.140 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2016 | 24 | 0.140 |
Why?
|
| Body Temperature | 1 | 2017 | 106 | 0.140 |
Why?
|
| Brain Edema | 1 | 2017 | 67 | 0.140 |
Why?
|
| Computational Biology | 1 | 2021 | 800 | 0.140 |
Why?
|
| Collagenases | 1 | 2014 | 18 | 0.120 |
Why?
|
| Thrombosis | 1 | 2019 | 519 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2002 | 2043 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2019 | 734 | 0.110 |
Why?
|
| Hypothermia, Induced | 1 | 2014 | 161 | 0.110 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 369 | 0.110 |
Why?
|
| Female | 6 | 2024 | 65442 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1907 | 0.100 |
Why?
|
| Humans | 8 | 2024 | 123152 | 0.090 |
Why?
|
| Tribolium | 1 | 2008 | 7 | 0.080 |
Why?
|
| Genes, Insect | 1 | 2008 | 123 | 0.070 |
Why?
|
| Disease Progression | 2 | 2024 | 2023 | 0.070 |
Why?
|
| Genome, Insect | 1 | 2008 | 95 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 3277 | 0.070 |
Why?
|
| Time Factors | 1 | 2017 | 6204 | 0.070 |
Why?
|
| Serotonergic Neurons | 1 | 2024 | 21 | 0.060 |
Why?
|
| Serotonin | 1 | 2024 | 222 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2023 | 98 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12116 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2023 | 264 | 0.050 |
Why?
|
| Chromatin | 1 | 2024 | 552 | 0.050 |
Why?
|
| Reference Standards | 1 | 2002 | 241 | 0.050 |
Why?
|
| Axons | 1 | 2023 | 380 | 0.040 |
Why?
|
| Cerebellum | 1 | 2024 | 415 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 617 | 0.040 |
Why?
|
| Synapses | 1 | 2023 | 448 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2023 | 333 | 0.040 |
Why?
|
| Motor Cortex | 1 | 2019 | 72 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1680 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2002 | 941 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 1870 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 2024 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 2112 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2023 | 2307 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2024 | 2047 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2014 | 81 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 2014 | 97 | 0.030 |
Why?
|
| Thrombin | 1 | 2014 | 60 | 0.030 |
Why?
|
| Blood Volume | 1 | 2014 | 80 | 0.030 |
Why?
|
| Hemostatics | 1 | 2014 | 57 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2024 | 2585 | 0.030 |
Why?
|
| Pregnancy | 1 | 2024 | 7137 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 6373 | 0.020 |
Why?
|
| Base Composition | 1 | 2008 | 72 | 0.020 |
Why?
|
| Growth and Development | 1 | 2008 | 22 | 0.020 |
Why?
|
| Receptors, Odorant | 1 | 2008 | 37 | 0.020 |
Why?
|
| Taste | 1 | 2008 | 32 | 0.020 |
Why?
|
| Oogenesis | 1 | 2008 | 52 | 0.020 |
Why?
|
| Insecticides | 1 | 2008 | 39 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 122 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2008 | 139 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2008 | 136 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2008 | 177 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 2008 | 123 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2008 | 367 | 0.020 |
Why?
|
| Telomere | 1 | 2008 | 206 | 0.020 |
Why?
|
| Proteome | 1 | 2008 | 233 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 496 | 0.020 |
Why?
|
| Phylogeny | 1 | 2008 | 685 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2008 | 280 | 0.020 |
Why?
|
| Aged | 1 | 2002 | 19069 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2002 | 15998 | 0.010 |
Why?
|
| Adolescent | 1 | 2002 | 19095 | 0.010 |
Why?
|
| Child | 1 | 2024 | 24223 | 0.010 |
Why?
|
| Middle Aged | 1 | 2002 | 25966 | 0.010 |
Why?
|
| Adult | 1 | 2002 | 29032 | 0.010 |
Why?
|